Dr Reddys Laboratories Ltd Dividend

US FDA Issues Form 483 With Five Observations at Dr Reddy’s Biologics Facility

 Copy Link

The inspection, conducted between September 4 and September 12, 2025, was a pre-approval review.

Top Stocks for Today - 15th September 2025

 Copy Link

Here are some of the stocks that may see significant price movement today: Apollo Hospitals, GMR Airports, RailTel Corporation, etc.

Dr Reddy’s Infuses ₹565 Cr into Russian Arm

 Copy Link

The capital was infused via cash and will be used to support DRL Russia’s working capital requirements.

Dr Reddy’s Laboratories inks pact with Alvotech; stock gains ~3%

 Copy Link

As per the terms agreement, Alvotech and Dr Reddy’s will jointly develop and manufacture the biosimilar candidate and share costs and responsibilities.

Dr. Reddy’s Receives Two USFDA Observations for New York API Manufacturing Plant

 Copy Link

Issuance of a Form 483 occurs when an investigator(s) has observed any conditions that in their judgment may constitute violations of the FD&C Act and related Acts.

Dr Reddy’s Q4 Profit Jumps 22% to ₹1,594 Crore

 Copy Link

The board has recommended a final dividend of ₹8 per equity share for FY 2024–25

Top Stocks for Today - 12th May 2025

 Copy Link

Here are some of the stocks that may see significant price movement today: Adani Power, Dr Reddy's, and Bank of India, etc.

Dr. Reddy’s Laboratories Sells 14 ANDAs to Senores Pharma

 Copy Link

Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.

Top Stocks for - 27th February 2025

 Copy Link

Here are some of the stocks that may see significant price movement today: KPI Green, Tata Power, UltraTech Cement, etc.

Dr Reddy’s Hyderabad API Unit Gets USFDA VAI Classification

 Copy Link

Dr Reddy's Laboratories third quarter net profit rose 2.5% year-on-year (YoY) to ₹1,413.3 crore.